239 related articles for article (PubMed ID: 18299171)
1. Re: Noburu Numao, Satoru Kawakami, Minato Yokoyama et al. Improved accuracy in predicting the presence of Gleason pattern 4/5 prostate cancer by three-dimensional 26-core systematic biopsy. Eur urol 2007;52:1663-9.
Boscolo-Berto R; Galfano A; Iafrate M
Eur Urol; 2008 Aug; 54(2):469-70; author reply 471. PubMed ID: 18299171
[No Abstract] [Full Text] [Related]
2. Editorial comment on: Improved accuracy in predicting the presence of gleason pattern 4/5 prostate cancer by three-dimensional 26-core systematic biopsy.
Remzi M
Eur Urol; 2007 Dec; 52(6):1668-9. PubMed ID: 17240039
[No Abstract] [Full Text] [Related]
3. Improved accuracy in predicting the presence of Gleason pattern 4/5 prostate cancer by three-dimensional 26-core systematic biopsy.
Numao N; Kawakami S; Yokoyama M; Yonese J; Arisawa C; Ishikawa Y; Ando M; Fukui I; Kihara K
Eur Urol; 2007 Dec; 52(6):1663-8. PubMed ID: 17240041
[TBL] [Abstract][Full Text] [Related]
4. Re: Diagnostic value of systematic biopsy methods in the investigation of prostate cancer: a systematic review. K. Eichler, S. Hempel, J. Wilby, L. Myers, L. M. Bachmann and J. Kleijnen, J Urol, 175: 1605-1612, 2006.
Eskicorapci SY; Tuncay L
J Urol; 2006 Dec; 176(6 Pt 1):2745; author reply 2745-6. PubMed ID: 17085209
[No Abstract] [Full Text] [Related]
5. Re: Felix K.-H. Chun, Thomas Steuber, Andreas Erbersdobler, et al. Development and internal validation of a nomogram predicting the probability of prostate cancer Gleason sum upgrading between biopsy and radical prostatectomy pathology. Eur Urol 2006;49:820-26.
Beckley I; Khan MA
Eur Urol; 2007 Oct; 52(4):1270; author reply 1271. PubMed ID: 17611016
[No Abstract] [Full Text] [Related]
6. Assessment of pathological prostate cancer characteristics in men with favorable biopsy features on predominantly sextant biopsy.
Chun FK; Suardi N; Capitanio U; Jeldres C; Ahyai S; Graefen M; Haese A; Steuber T; Erbersdobler A; Montorsi F; Huland H; Karakiewicz PI
Eur Urol; 2009 Mar; 55(3):617-28-6. PubMed ID: 18499335
[TBL] [Abstract][Full Text] [Related]
7. Improving cancer detection by prostate biopsy: the role of core number and site.
Shinohara K
Nat Clin Pract Urol; 2006 Oct; 3(10):526-7. PubMed ID: 17031375
[No Abstract] [Full Text] [Related]
8. A prospective randomised trial of extended core prostate biopsy protocols utilizing 12 versus 15 cores.
Rochester MA; Griffin S; Chappell B; McLoughlin J
Urol Int; 2009; 83(2):155-9. PubMed ID: 19752609
[TBL] [Abstract][Full Text] [Related]
9. Biopsy core number represents one of foremost predictors of clinically significant gleason sum upgrading in patients with low-risk prostate cancer.
Capitanio U; Karakiewicz PI; Valiquette L; Perrotte P; Jeldres C; Briganti A; Gallina A; Suardi N; Cestari A; Guazzoni G; Salonia A; Montorsi F
Urology; 2009 May; 73(5):1087-91. PubMed ID: 19195695
[TBL] [Abstract][Full Text] [Related]
10. Usefulness of the 2005 International Society of Urological Pathology Gleason Grading System in prostate biopsy and radical prostatectomy specimens.
Trpkov K; Zhang J
BJU Int; 2009 Sep; 104(5):722-3. PubMed ID: 19689580
[No Abstract] [Full Text] [Related]
11. Re: Urs E. Studer, Laurence Collette, Peter Whelan, et al. Using PSA to guide timing of androgen deprivation in patients with T0-4 N0-2 M0 prostate cancer not suitable for local curative treatment (EORTC 30891). Eur Urol 2008;53:941-9 and re: John Anderson. Androgen-deprivation therapy--It's all a matter of timing. Eur Urol 2008;53:869-71.
Kirollos MM
Eur Urol; 2009 Feb; 55(2):e40-2; author reply e45-6. PubMed ID: 18760526
[No Abstract] [Full Text] [Related]
12. Importance of peripheral biopsies in maximising the detection of early prostate cancer in repeat 12-core biopsy protocols.
Kumar V
BJU Int; 2007 Jan; 99(1):209-10; author reply 210. PubMed ID: 17227502
[No Abstract] [Full Text] [Related]
13. Re: The 20-core prostate biopsy protocol--a new gold standard?: V. Ravery, S. Dominique, X. Panhard, M. Toublanc, L. Boccon-Gibod and L. Boccon-Gibod. J Urol 2008; 179: 504-507.
Serefoglu EC; Ozdemir AT; Balbay MD
J Urol; 2008 Nov; 180(5):2256-7. PubMed ID: 18804806
[No Abstract] [Full Text] [Related]
14. Prostate cancers diagnosed at repeat biopsy are smaller and less likely to be high grade.
Tan N; Lane BR; Li J; Moussa AS; Soriano M; Jones JS
J Urol; 2008 Oct; 180(4):1325-9; discussion 1329. PubMed ID: 18707706
[TBL] [Abstract][Full Text] [Related]
15. Re: Risk of prostate cancer after diagnosis of atypical glands suspicious for carcinoma on saturation and traditional biopsies: R. Abouassaly, N. Tan, A. Moussa and J. S. Jones J Urol 2008; 180: 911-914.
Feldstein MS; Hentz JG
J Urol; 2009 Apr; 181(4):1960-1; author reply 1961. PubMed ID: 19251278
[No Abstract] [Full Text] [Related]
16. Saturation biopsy for detecting and characterizing prostate cancer.
Jones JS
BJU Int; 2007 Jun; 99(6):1340-4. PubMed ID: 17428241
[No Abstract] [Full Text] [Related]
17. Anterior apical biopsy: is it useful for prostate cancer detection?
Orikasa K; Ito A; Ishidoya S; Saito S; Endo M; Arai Y
Int J Urol; 2008 Oct; 15(10):900-4; discussion 904. PubMed ID: 18657203
[TBL] [Abstract][Full Text] [Related]
18. Intensifying the saturation biopsy technique for detecting prostate cancer after previous negative biopsies: a step in the wrong direction.
Bott S; Langley S; Hindley R; Montgomery B
BJU Int; 2009 Mar; 103(5):701. PubMed ID: 19226428
[No Abstract] [Full Text] [Related]
19. [Fine needle aspiration and simple needle biopsy of the prostate].
Shental J; Sudarsky M; Scheiber M; Buium D; Levy E
Harefuah; 1981 Mar; 100(5):211-3. PubMed ID: 7286811
[No Abstract] [Full Text] [Related]
20. Prostatic transition zone directed needle biopsies uncommonly sample clinically relevant transition zone tumors.
Haarer CF; Gopalan A; Tickoo SK; Scardino PT; Eastham JA; Reuter VE; Fine SW
J Urol; 2009 Oct; 182(4):1337-41. PubMed ID: 19683261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
